New appointments in the pharmaceutical industry
With his 20 years of expertise and proven track record in biotech and pharmaceutical industries, Curve Therapeutics appoints Simon Jones as chief financial officer and chief operating officer.
Vectory Therapeutics has announced the appointment of Adam Rosenberg as chair of the board, replacin Dr Carlo Incerti.
Mogrify has announced the appointment of Dr Jonathan Appleby as chief scientific officer.
Professor Yih-Shing Duh appointed as chief scientific advisor by H.E.L. Group
Enhanc3D Genomics has announced the appointment of Hazel Jones as chief executive officer (CEO), following a successful six-month term as interim CEO and COO.
Closed loop medicine has announced the appointment of Paul Johnson as an independent non-executive director.
Sphere Fluidics has announced the appointment of Curtis Nicholson as director for sales for Europe, Middle East and Africa (EMEA).
Drug Safety Research Unit appoints Dr Alison Evans as head of education and training.
Calluna Pharma has announced that it has appointed Margrethe Sørgaard as senior vice president of clinical operations and pharmacovigilance.
Sakura Finetek Europe has announced the appointment of Jaap Stuut as president and general manager, effective immediately.
Harness Therapeutics has announced the appointment of Meenu Chhabra Karson as chair of its board of directors.
Single Technologies has announced that it has appointed Bob Kain as an advisor to support the commercialisation of its 3D sequencing system.